$ULBI
ULTRALIFE CORP

2022 Q3 Form 10-Q Financial Statement

#000143774922017943 Filed on July 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $33.23M $32.13M $30.37M
YoY Change 52.72% 20.01% 16.94%
Cost Of Revenue $26.52M $24.48M $23.42M
YoY Change 59.24% 25.52% 23.27%
Gross Profit $6.715M $7.646M $6.958M
YoY Change 31.46% 5.22% -0.29%
Gross Profit Margin 20.21% 23.8% 22.91%
Selling, General & Admin $5.405M $5.181M $5.396M
YoY Change 29.8% 19.85% 23.22%
% of Gross Profit 80.49% 67.76% 77.55%
Research & Development $1.896M $1.672M $1.857M
YoY Change 10.04% -9.77% 12.75%
% of Gross Profit 28.24% 21.87% 26.69%
Depreciation & Amortization $815.0K $819.0K $816.0K
YoY Change 16.43% 12.19% 11.78%
% of Gross Profit 12.14% 10.71% 11.73%
Operating Expenses $7.301M $6.853M $7.253M
YoY Change 24.02% 10.96% 20.36%
Operating Profit -$586.0K $793.0K -$295.0K
YoY Change -24.78% -27.31% -130.99%
Interest Expense -$272.0K -$177.0K -$134.0K
YoY Change 413.21% 221.82% 123.33%
% of Operating Profit -22.32%
Other Income/Expense, Net $254.0K -$115.0K -$117.0K
YoY Change 25300.0% 447.62% 108.93%
Pretax Income -$332.0K $678.0K -$412.0K
YoY Change -57.33% -36.64% -145.98%
Income Tax -$90.00K $170.0K -$251.0K
% Of Pretax Income 25.07%
Net Earnings -$239.0K $512.0K -$168.0K
YoY Change -59.15% -36.87% -125.04%
Net Earnings / Revenue -0.72% 1.59% -0.55%
Basic Earnings Per Share $0.03 $0.03 -$1.00
Diluted Earnings Per Share $0.03 $0.03 -$1.00
COMMON SHARES
Basic Shares Outstanding 16.13M 16.13M 16.10M
Diluted Shares Outstanding 16.13M 16.15M 16.10M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.051M $5.114M $6.050M
YoY Change -68.14% -67.69% -55.84%
Cash & Equivalents $4.978M $5.037M $5.968M
Short-Term Investments
Other Short-Term Assets $6.241M $5.161M $3.803M
YoY Change 46.13% 119.52% 35.82%
Inventory $40.77M $39.20M $36.38M
Prepaid Expenses
Receivables $26.88M $22.35M $22.91M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $78.94M $71.83M $69.14M
YoY Change 22.31% 11.69% 8.85%
LONG-TERM ASSETS
Property, Plant & Equipment $21.90M $22.34M $22.34M
YoY Change -4.94% -1.68% -2.65%
Goodwill $37.07M $37.50M $37.93M
YoY Change 37.29% 38.31% 40.15%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.981M $2.261M $2.701M
YoY Change 9.09% 13.9% 26.57%
Total Long-Term Assets $89.00M $90.40M $92.25M
YoY Change 23.15% 25.18% 26.59%
TOTAL ASSETS
Total Short-Term Assets $78.94M $71.83M $69.14M
Total Long-Term Assets $89.00M $90.40M $92.25M
Total Assets $167.9M $162.2M $161.4M
YoY Change 22.75% 18.83% 18.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.83M $13.44M $11.24M
YoY Change 71.92% 40.82% 10.79%
Accrued Expenses $10.25M $6.735M $6.780M
YoY Change 41.85% 25.61% 23.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $2.000M $2.000M
YoY Change 690.51% 220.51% 101.41%
Total Short-Term Liabilities $28.08M $22.18M $20.02M
YoY Change 68.27% 42.79% 20.32%
LONG-TERM LIABILITIES
Long-Term Debt $20.87M $19.57M $19.98M
YoY Change
Other Long-Term Liabilities $1.673M $1.328M $1.574M
YoY Change 51.68% 5.4% 13.24%
Total Long-Term Liabilities $22.55M $20.89M $21.56M
YoY Change 1944.15% 1558.25% 1450.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.08M $22.18M $20.02M
Total Long-Term Liabilities $22.55M $20.89M $21.56M
Total Liabilities $52.62M $45.16M $43.75M
YoY Change 188.1% 161.27% 136.11%
SHAREHOLDERS EQUITY
Retained Earnings -$47.73M -$47.49M -$48.00M
YoY Change 2.2% 2.98% 2.29%
Common Stock $2.057M $2.057M $2.056M
YoY Change 0.29% 0.49% 0.69%
Preferred Stock
YoY Change
Treasury Stock (at cost) $21.48M $21.48M $21.48M
YoY Change 0.05% 0.43% 0.45%
Treasury Stock Shares $4.435M $4.435M $4.434M
Shareholders Equity $115.2M $116.9M $117.5M
YoY Change
Total Liabilities & Shareholders Equity $167.9M $162.2M $161.4M
YoY Change 22.75% 18.83% 18.33%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$239.0K $512.0K -$168.0K
YoY Change -59.15% -36.87% -125.04%
Depreciation, Depletion And Amortization $815.0K $819.0K $816.0K
YoY Change 16.43% 12.19% 11.78%
Cash From Operating Activities -$427.0K -$178.0K -$3.222M
YoY Change -128.33% -105.83% -182.55%
INVESTING ACTIVITIES
Capital Expenditures -$811.0K -$214.0K $371.0K
YoY Change -26.21% -70.88% -24.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$811.0K -$214.0K -$371.0K
YoY Change -26.21% -70.88% -24.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.303M -429.0K $1.223M
YoY Change -430.71% 251.64% -391.19%
NET CHANGE
Cash From Operating Activities -427.0K -178.0K -$3.222M
Cash From Investing Activities -811.0K -214.0K -$371.0K
Cash From Financing Activities 1.303M -429.0K $1.223M
Net Change In Cash 65.00K -821.0K -$2.363M
YoY Change 364.29% -137.35% -178.53%
FREE CASH FLOW
Cash From Operating Activities -$427.0K -$178.0K -$3.222M
Capital Expenditures -$811.0K -$214.0K $371.0K
Free Cash Flow $384.0K $36.00K -$3.593M
YoY Change -85.26% -99.05% -205.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
197000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
dei Entity Central Index Key
EntityCentralIndexKey
0000875657
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.305 pure
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
283000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-20852
dei Entity Registrant Name
EntityRegistrantName
ULTRALIFE CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
2000 Technology Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Newark
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14513
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1387013
dei City Area Code
CityAreaCode
315
dei Local Phone Number
LocalPhoneNumber
332-7100
dei Security12b Title
Security12bTitle
Common Stock, $0.10 par value per share
dei Trading Symbol
TradingSymbol
ULBI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16132868
CY2022Q2 us-gaap Cash
Cash
5114000 usd
CY2021Q4 us-gaap Cash
Cash
8413000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
316000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
346000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22349000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20232000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
39201000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
33189000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5161000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4690000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
71825000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
66524000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22338000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23205000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
37502000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
38068000 usd
CY2022Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
16566000 usd
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
17390000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11731000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11472000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2261000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2879000 usd
CY2022Q2 us-gaap Assets
Assets
162223000 usd
CY2021Q4 us-gaap Assets
Assets
159538000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13441000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9823000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1924000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1842000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4811000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5259000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22176000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18924000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19566000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18857000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2086000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2254000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1328000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1760000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
45156000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
41795000 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20522427
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16089832
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2052000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186518000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47832000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3151000 usd
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4432595
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
21469000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117616000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
127000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000 usd
us-gaap Net Income Loss
NetIncomeLoss
1482000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1498000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
196000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
904000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1154000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1678000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16129000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16019000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16116000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15997000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20000
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
241000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16149000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16260000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16141000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16194000
us-gaap Profit Loss
ProfitLoss
347000 usd
us-gaap Profit Loss
ProfitLoss
1501000 usd
us-gaap Depreciation
Depreciation
1460000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
310000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
52000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
370000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-345000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2385000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2390000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6606000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-864000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-104000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2536000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2839000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2873000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3400000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6955000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
585000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1225000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-585000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1225000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1550000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
833000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
789000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
113000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
314000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
25000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
67000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
794000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-542000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-108000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5175000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5114000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15828000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116923000 usd
us-gaap Profit Loss
ProfitLoss
1501000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
262000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
196000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119237000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117743000 usd
us-gaap Profit Loss
ProfitLoss
347000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
337000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
33000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
106000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
362000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
11000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-1498000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117067000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117861000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
822000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
283000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
174000 usd
CY2021Q2 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
12000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-8000 usd
CY2021Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
93000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119237000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117641000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
508000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
181000 usd
CY2022Q2 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
3000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4000 usd
CY2022Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-1262000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117067000 usd
CY2022Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
135163
CY2022Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20352
CY2021Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
906404
CY2021Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
14164
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
240259
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
135163
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
659488
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5000
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
14164
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24751
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
197848
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5037000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8329000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
77000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
84000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5114000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8413000 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26209000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
21660000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3526000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4227000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9466000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7302000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
39201000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
33189000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91888000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91423000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69550000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68218000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22338000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23205000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
819000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
730000 usd
us-gaap Depreciation
Depreciation
1635000 usd
us-gaap Depreciation
Depreciation
1460000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
38068000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-30000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-536000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
37502000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28076000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11510000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16566000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28454000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11064000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237 pure
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
226000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
189000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17390000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
323000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
156000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
651000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
310000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
184000 usd
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
186000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
373000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
370000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1306824
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.68
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
58750
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
44834
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.76
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1208240
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y25D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1103948
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.01
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y11M4D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
33000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
717956
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y11M4D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
33000 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
458000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
376000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
23000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
13000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
47000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
32000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
249000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
202000 usd
us-gaap Lease Cost
LeaseCost
505000 usd
us-gaap Lease Cost
LeaseCost
408000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
449000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
365000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
440000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
871000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
449000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
136000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
137000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
137000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
281000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2451000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
280000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
133000 usd
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
149000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
25000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
121000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
26000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
108000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
132000 usd
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
162000 usd
CY2022Q2 us-gaap Revenues
Revenues
32126000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
793000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-115000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
170000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
512000 usd
CY2021Q2 us-gaap Revenues
Revenues
26770000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1091000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
248000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
811000 usd
us-gaap Revenues
Revenues
62499000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
498000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-232000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000 usd
us-gaap Net Income Loss
NetIncomeLoss
344000 usd
us-gaap Revenues
Revenues
52743000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2043000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-77000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
465000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000 usd
us-gaap Net Income Loss
NetIncomeLoss
1482000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32126000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26770000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
62499000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52743000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32126000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26770000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
62499000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52743000 usd

Files In Submission

Name View Source Status
0001437749-22-017943-index-headers.html Edgar Link pending
0001437749-22-017943-index.html Edgar Link pending
0001437749-22-017943.txt Edgar Link pending
0001437749-22-017943-xbrl.zip Edgar Link pending
ex_397800.htm Edgar Link pending
ex_397801.htm Edgar Link pending
ex_397802.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20220630.xsd Edgar Link pending
ulbi-20220630_cal.xml Edgar Link unprocessable
ulbi-20220630_def.xml Edgar Link unprocessable
ulbi-20220630_lab.xml Edgar Link unprocessable
ulbi-20220630_pre.xml Edgar Link unprocessable
ulbi20220630_10q.htm Edgar Link pending
ulbi20220630_10q_htm.xml Edgar Link completed